SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.430.0%Dec 3 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harold Engstrom who wrote (755)9/27/2000 11:40:23 AM
From: scaram(o)uche  Read Replies (1) of 1475
 
"In
what's known as a "proof-of-concept" test, MedImmune will use the
psoriasis trials to see if Medi-507 can work on other autoimmune
diseases, such as rheumatoid arthritis, multiple sclerosis and Crohn's
disease."

excerpts from.......

Heard in New England:
BioTransplant Fans See Big Things
In Company's Psoriasis Treatment
----
By Andrew Caffrey
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News